New NIAID Strategic Plan Focuses on Infectious and Immune-Mediated Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) recently published its 2026-2030 Strategic Plan, the institute’s first major strategic…
Policy
Read Full News
AAI Weighs in on NIH Peer Review Transparency and Biosafety Modernization
This October, AAI submitted comments in response to two National Institutes of Health (NIH) Requests for Information (RFIs): one seeking…
AAI Visits Capitol Hill as Sponsor of 14th Annual Rally for Medical Research
On September 17, nearly 300 scientists, medical professionals, patient advocates, and policy professionals converged on Capitol Hill for the 14th…
Combating Chronic Disease: AAI Congressional Briefing on Alzheimer’s Disease Research
On September 2, in a hearing room of the Hart Senate Office Building, AAI held a congressional briefing to help…
AAI Leaders Meet with NIH Officials to Discuss Shared Priorities
On August 12, select AAI leaders and staff spent the day on the NIH campus in Bethesda, Maryland, meeting with…
Executive Order on Childhood Vaccines Risks Increasing Preventable Illness and Deaths
The Executive Order released by the White House on August 10, 2026, undermines trust in childhood vaccines by promoting narratives…
AAI Statement on Executive Order Revising Childhood Vaccine Recommendations
AAI is alarmed by the Administration’s decision to issue unscientific recommendations for childhood vaccines outside the established, evidence-based processes that have long guided U.S. immunization policy.
AAI Condemns Continued Efforts to Politicize Science and Discredit Scientists
The American Association of Immunologists (AAI) is appalled by the continuing efforts to target Anthony S. Fauci, MD, AAI member…
AAI Expresses Strong Opposition to OMB Proposed Rule on Federal Financial Assistance
Update to article, August 8, 2026: On August 8, the Senate approved a continuing resolution (CR) that includes a provision preventing the White House Office…
AAI Supports the Nomination of Dr. Erica Schwartz as CDC Director
At a time when the nation faces significant public health challenges, strong scientific leadership at the CDC is essential. Dr. Erica Schwartz brings an impressive combination of clinical expertise, public health experience, and proven leadership.